{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T07:02:50Z","timestamp":1779692570247,"version":"3.53.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although magnesium acts as a natural calcium antagonist with theoretical cardioprotective effects, its clinical value in critically ill patients with acute myocardial infarction (AMI) remains controversial. This study aimed to evaluate the impact of intravenous magnesium sulfate on ICU mortality in this population, and to explore potential dose-response relationships and effect modifiers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study utilized the single-center Medical Information Mart for Intensive Care-IV version 3.1 (MIMIC-IV v3.1) database, which comprises patients admitted to Beth Israel Deaconess Medical Center, to examine the association between intravenous magnesium sulfate administration and mortality in critically ill patients with AMI. The primary endpoint was ICU mortality. Multivariable Cox regression, propensity score matching, and propensity score weighting were employed to control for confounders and estimate the independent effect of magnesium sulfate administration. Additional analyses included assessment of the restricted mean survival time (RMST) and quantitative evaluation of unmeasured confounding using the E-value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study included 5,650 critically ill patients with AMI. In the propensity score-matched analysis, intravenous magnesium sulfate administration was associated with a 45% reduction in ICU mortality risk (HR 0.55, 95% CI 0.42\u20130.71). RMST analysis confirmed an absolute survival benefit of 1.64 days at 14 days. A consistent reduction in mortality risk was observed across all secondary endpoints. A clear dose-response relationship was identified, with the greatest survival benefit at moderate cumulative doses (2.0\u20138.0\u00a0g) and treatment durations (1.08\u20133.21 days). The association remained robust to potential unmeasured confounding (E-value = 2.66). Subgroup analyses demonstrated consistent protective effects across all patient strata.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Intravenous magnesium sulfate administration is associated with lower ICU mortality in critically ill patients with AMI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1776926","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:05:13Z","timestamp":1779689113000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of magnesium sulfate administration on outcomes in ICU patients with acute myocardial infarction: a retrospective cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Guibao","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Huian County Hospital","place":["Quanzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangzhi","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Huian County Hospital","place":["Quanzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Second Hospital of Shanxi Medical University","place":["Taiyuan, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Respiratory Intensive Care Unit, Second Hospital of Shanxi Medical University","place":["Taiyuan, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Intensive Care Unit, Second Hospital of Shanxi Medical University","place":["Taiyuan, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Respiratory Intensive Care Unit, Second Hospital of Shanxi Medical University","place":["Taiyuan, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Intensive Care Unit, Second Hospital of Shanxi Medical University","place":["Taiyuan, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Intensive Care Unit, Second Hospital of Shanxi Medical University","place":["Taiyuan, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Huian County Hospital","place":["Quanzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wengui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Huian County Hospital","place":["Quanzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Critical Care, The Second Affiliated Hospital of Guangzhou Medical University","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Respiratory Intensive Care Unit, Second Hospital of Shanxi Medical University","place":["Taiyuan, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3390\/medicina59071190","article-title":"Hypermagnesemia in clinical practice","volume":"59","author":"Aal-Hamad","year":"2023","journal-title":"Med. Mex."},{"key":"B2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.21037\/atm.2018.01.03","article-title":"The potential detrimental effects of calcium channel blockers\u2019 overdose and current available management","volume":"6","author":"Agarwal","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S0140-6736(02)11278-5","article-title":"Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the magnesium in coronaries (MAGIC) trial: a randomised controlled trial","volume":"360","author":"Antman","year":"2002","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s41043-023-00423-0","article-title":"A narrative review on the role of magnesium in immune regulation, inflammation, infectious diseases, and cancer","volume":"42","author":"Ashique","year":"2023","journal-title":"J. Health Popul. Nutr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"pvw028","DOI":"10.1093\/ehjcvp\/pvw028","article-title":"Treating arrhythmias with adjunctive magnesium: identifying future research directions","volume":"3","author":"Baker","year":"2016","journal-title":"Eur. Heart J. Cardiovasc Pharmacother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"111338","DOI":"10.1016\/j.jclinepi.2024.111338","article-title":"Use and reporting of inverse-probability-of-treatment weighting for multicategory treatments in medical research: a systematic review","volume":"170","author":"Bettega","year":"2024","journal-title":"J. Clin. Epidemiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/ejhf.1922","article-title":"Epidemiology, pathophysiology and contemporary management of cardiogenic shock \u2013 a position statement from the heart failure association of the european society of cardiology","volume":"22","author":"Chioncel","year":"2020","journal-title":"Eur. J. Heart Fail"},{"key":"B8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J. Anaesth."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00012.2014","article-title":"Magnesium in man: implications for health and disease","volume":"95","author":"De Baaij","year":"2015","journal-title":"Physiol. Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12933-025-02697-6","article-title":"Association between triglyceride\u2013glucose index and mortality in critically ill patients with atrial fibrillation: a retrospective cohort study","volume":"24","author":"Ding","year":"2025","journal-title":"Cardiovasc Diabetol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S0735-1097(98)00231-9","article-title":"Magnesium reduces free radicals in an in vivo coronary occlusion-reperfusion model","volume":"32","author":"Garcia","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"B12","first-page":"65","article-title":"Serum magnesium level and it\u2019s relation in predicting adverse In-hospital outcome in patients with first attack of myocardial infarction","volume":"32","author":"Hasan","year":"2023","journal-title":"Mymensingh Med. J. MMJ"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1161\/01.CIR.92.9.2622","article-title":"Timing of magnesium therapy affects experimental infarct size","volume":"92","author":"Herzog","year":"1995","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1751-7176.2011.00538.x","article-title":"The role of magnesium in hypertension and cardiovascular disease","volume":"13","author":"Houston","year":"2011","journal-title":"J. Clin. Hypertens."},{"key":"B15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","article-title":"ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (fourth international study of infarct survival) collaborative group","volume":"345","year":"1995","journal-title":"Lancet lond Engl"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci. Data"},{"key":"B17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/ehjacc\/zuaf118","article-title":"Cardiogenic shock as a complication of acute myocardial infarction: a nationwide cohort study","volume":"15","author":"Jortveit","year":"2025","journal-title":"Eur. Heart J. Acute Cardiovasc Care"},{"key":"B18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archinte.1987.00370030069014","article-title":"Serum magnesium and potassium in acute myocardial infarction. Influence on ventricular arrhythmias","volume":"147","author":"Kafka","year":"1987","journal-title":"Arch. Intern Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/CRD.0000000000000003","article-title":"Role of magnesium in cardiovascular diseases","volume":"22","author":"Kolte","year":"2014","journal-title":"Cardiol. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1093\/ndt\/gfae134","article-title":"Magnesium biology","volume":"39","author":"Kr\u00f6se","year":"2024","journal-title":"Nephrol. Dial. Transpl."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.2174\/0113816128321466240816075041","article-title":"Magnesium (Mg2+): essential mineral for neuronal health: from cellular biochemistry to cognitive health and behavior regulation","volume":"30","author":"Kumar","year":"2024","journal-title":"Curr. Pharm. Des."},{"key":"B22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/ijciis.ijciis_11_23","article-title":"An assessment of serum magnesium levels in critically ill patients: a prospective observational study","volume":"13","author":"Laddhad","year":"2023","journal-title":"Int. J. Crit. Illn. Inj. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s10565-024-09910-4","article-title":"Metal ions overloading and cell death","volume":"40","author":"Lai","year":"2024","journal-title":"Cell Biol. Toxicol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cvsm.2025.08.002","article-title":"Magnesium in the critically ill patient","volume":"56","author":"Llewellyn","year":"2026","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"B25","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S0008-6363(02)00253-5","article-title":"Magnesium reduces myocardial infarct size via enhancement of adenosine mechanism in rabbits","volume":"54","author":"Matsusaka","year":"2002","journal-title":"Cardiovasc Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.3390\/biomedicines10102356","article-title":"The role of hypomagnesemia in cardiac arrhythmias: a clinical perspective","volume":"10","author":"Negru","year":"2022","journal-title":"Biomedicines"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e25839","DOI":"10.7759\/cureus.25839","article-title":"Magnesium and hypertension: decoding novel anti-hypertensives","volume":"14","author":"Patni","year":"2022","journal-title":"Cureus"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001309","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1001\/jama.2021.18323","article-title":"Cardiogenic shock after acute myocardial infarction: a review","volume":"326","author":"Samsky","year":"2021","journal-title":"JAMA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.3390\/nu13113880","article-title":"Dose-dependent neuroprotective effects of bovine lactoferrin following neonatal hypoxia\u2013ischemia in the immature rat brain","volume":"13","author":"Sanches","year":"2021","journal-title":"Nutrients"},{"key":"B31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejim.2024.10.024","article-title":"Translating evidence into practice: managing electrolyte imbalances and iron deficiency in heart failure","volume":"131","author":"Sato","year":"2025","journal-title":"Eur. J. Intern Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2165\/00129784-200303040-00001","article-title":"Does magnesium have a role in the treatment of patients with coronary artery disease?","volume":"3","author":"Shechter","year":"2003","journal-title":"Am. J. Cardiovasc Drugs"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1161\/01.cir.102.19.2353","article-title":"Oral magnesium therapy improves endothelial function in patients with coronary artery disease","volume":"102","author":"Shechter","year":"2000","journal-title":"Circulation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/0885066607310181","article-title":"Efficacy of magnesium-amiodarone Step-Up scheme in critically ill patients with new-onset atrial fibrillation: a prospective observational study","volume":"23","author":"Sleeswijk","year":"2008","journal-title":"J. Intensive Care Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"608193","DOI":"10.3389\/fcvm.2020.608193","article-title":"The effect of magnesium on reperfusion arrhythmias in STEMI patients, treated with PPCI. A systematic review with a meta-analysis and trial sequential analysis","volume":"7","author":"Szapary","year":"2021","journal-title":"Front. Cardiovasc Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1053\/j.ackd.2018.02.010","article-title":"Magnesium and cardiovascular disease","volume":"25","author":"Tangvoraphonkchai","year":"2018","journal-title":"Adv. Chronic Kidney Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","article-title":"Extracorporeal life support in infarct-related cardiogenic shock","volume":"389","author":"Thiele","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(94)92024-9","article-title":"Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second leicester intravenous magnesium intervention trial (LIMIT-2)","volume":"343","author":"Woods","year":"1994","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/0140-6736(92)91828-v","article-title":"Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second leicester intravenous magnesium intervention trial (LIMIT-2)","volume":"339","author":"Woods","year":"1992","journal-title":"Lancet lond Engl."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1776926\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:05:14Z","timestamp":1779689114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1776926\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":41,"alternative-id":["10.3389\/fphar.2026.1776926"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1776926","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"article-number":"1776926"}}